| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | -0.0021 | 0.9 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | 0.0027 | 1 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.0024 | 1 |